UNSPSC 51285400: A-generational cephalosporins

This classification denotes a variety of medium-spectrum antibiotics originally isolated from the fungus cephalosporium acremonium, and which contain thia-azabicyclo-octenecarboxylic acid or 7-aminocephalosporanic acid, but which medical researchers have not yet designated as First-, Second-, Third-, Fourth-, or Fifth-Generation, hence the term A-GENERATIONAL CEPHALOSPORINS.

UNSPSC 51285400 A-generational cephalosporins is a Class code, but the recent state and local opportunities tagged under it show minimal alignment with the code's pharmaceutical scope. The solicitations involve naloxone and drug deactivation systems, direct-to-manufacturer prescription initiatives, medical and first aid supplies for emergency response, and generic multi-source pharmaceuticals and OTC products — none of which center on cephalosporin antibiotics. State and local buyers do purchase pharmaceuticals through cooperative and individual procurement vehicles, but the available records do not demonstrate active solicitation demand specifically for A-generational cephalosporin products. The code appears to show little relevant recent activity; the mismatch between the code's nominal scope and the work actually being bought suggests either miscoding in the source data or minimal current state and local procurement interest in this antibiotic class.

The geographic spread of pharmaceutical procurement activity across the captured opportunities spans Florida, Texas, and Minnesota, with activity also touching Oregon through the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP). Issuing bodies include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS), municipal fire services (City of Tampa), and cooperative purchasing consortia (MMCAP). Representative recent solicitations include Seminole County's IFB for naloxone and drug deactivation systems with a response deadline of July 26, 2023; the City of Tampa's invitation to bid for medical and first aid supplies for the Fire Department Rescue Division with a response deadline of March 13, 2026 and an estimated contract value of $700,000.00, restricted to certified Small Local Business Enterprises; and MMCAP's RFP for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026. Given the code-scope mismatch and absence of cephalosporin-specific solicitations, pursuit under this code is not recommended without validation of actual buying patterns.